 Autoantibodies cells helper defects human immunodeficiency virus-infected patients autoantibodies lymphocytes dysfunction autoantibody formation T-cell function hemophilia patients patients human immunodeficiency virus HIV HIV-positive stage CDC II III HIV-positive stage CDC IV subsets lymphocytes mitogen PWM days Ig-secreting cells reverse hemolytic plaque assay presence IgM IgG surface cells subsets flow cytometry Autoantibodies cells controls HIV-negative patients common HIV-positive patients patients patients autoantibodies increased incidence helper defects CDC II III patients CDC IV patients patients IgM autoantibodies IgG autoantibodies helper defects Complement fixation relevance Autoantibody formation cells due vivo B-cell stimulation spontaneous plaque formation cells autoantibody-negative patients cells autoantibody-positive patients significant results autoantibody formation general state vivo B-cell activation production autoantibodies defects B-cell proliferation differentiation reduced mitogen-stimulated B-cell responses CDC II III patients cells pathogenesis helper defects HIV-infected patients